Publication Date
7-26-2021
Journal
World Journal of Cardiology
DOI
10.4330/wjc.v13.i7.223
PMID
34367506
PMCID
PMC8326154
PubMedCentral® Posted Date
7-26-2021
PubMedCentral® Full Text Version
Post-print
Published Open-Access
yes
Keywords
Fractional flow reserve, Coronary guidewire, Adverse events, Modes of failure, Food and Drug Administration, Manufacturer and user facility device experience
Abstract
BACKGROUND: Fractional flow reserve (FFR) measurement is commonly used in the cardiac catheterization laboratory to assess the functional significance of coronary arterial plaques. Robust real-world data on complications and modes of failure of FFR guidewires are limited.
AIM: To characterize these outcomes by analyzing the post-marketing surveillance data from the United States Food and Drug Administration Manufacturer and User Facility Device Experience (MAUDE) database for commonly used FFR guidewires.
METHODS: The MAUDE database was queried from January 2010 through April 2020 for 3 FFR guidewires [PressureWire
RESULTS: Guidewire tip fracture was the most commonly reported mode of failure, in 174 (35.8%) cases followed by guidewire kinking (
CONCLUSION: FFR guidewire failures can occur because of various mechanisms and cause patient adverse events. The MAUDE database serves as an important platform for improved collaboration among clinicians, device manufacturers, and regulators to improve device performance and optimize patient outcomes. Our analysis provides mechanistic insights of FFR guidewire failure and associated adverse events but cannot verify causality or provide a comparison among different guidewires.
Comments
Associated Data